Literature DB >> 2488232

Cellular proteins that are targetted by DNA tumor viruses for transformation.

N Dyson1, K Buchkovich, P Whyte, E Harlow.   

Abstract

Tumor suppressor genes are genetic loci whose loss is associated with tumor development. Because the inactivation of these genes is a key feature in the genesis of certain tumors, it has been postulated that the protein products of tumor suppressor genes function in the negative regulation of cell proliferation. Tumor suppressor genes have been identified by genetic analysis either as loci associated with an inherited predisposition to certain tumors or by mapping studies that demonstrate allelic loss (reduction to homozygosity or loss of heterozygosity) during tumor development. The retinoblastoma gene, RB-1, was originally identified and cloned through its association with childhood retinoblastoma and is one of the best studied examples of the tumor suppressor genes. It has been shown that RB protein is also a key target for transformation by the oncogenes of several small DNA tumor viruses. The E1A proteins of adenovirus, the large T antigens of polyomaviruses, and E7 proteins of papillomaviruses all bind to pRB. Genetic studies of all three viruses have shown that any mutation that destroys binding to pRB also destroys the ability of these proteins to transform cells, suggesting that interaction with the RB gene product is a key event in viral transformation. In addition to interacting with pRB, the adenovirus E1A proteins and the polyomavirus large T antigens also bind to other cellular proteins. One of these, a protein with a molecular weight 0f 107,000 daltons, 107K, binds to E1A and large T at the same amino acid region as pRB, suggesting that the 107K and pRB proteins may have structural similarities.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2488232

Source DB:  PubMed          Journal:  Princess Takamatsu Symp


  13 in total

Review 1.  Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression.

Authors:  Oishee Chakrabarti; Sudhir Krishna
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

2.  Targeting tumor suppressor networks for cancer therapeutics.

Authors:  Xuning Emily Guo; Bryan Ngo; Aram Sandaldjian Modrek; Wen-Hwa Lee
Journal:  Curr Drug Targets       Date:  2014-01       Impact factor: 3.465

Review 3.  DNA virus replication compartments.

Authors:  Melanie Schmid; Thomas Speiseder; Thomas Dobner; Ramon A Gonzalez
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

4.  Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein.

Authors:  Seetharaman Balasenthil; Ratna K Vadlamudi
Journal:  J Biol Chem       Date:  2003-04-07       Impact factor: 5.157

5.  Enumeration of the simian virus 40 early region elements necessary for human cell transformation.

Authors:  William C Hahn; Scott K Dessain; Mary W Brooks; Jessie E King; Brian Elenbaas; David M Sabatini; James A DeCaprio; Robert A Weinberg
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

6.  E7 abolishes raf-induced arrest via mislocalization of p21(Cip1).

Authors:  Thomas F Westbrook; Don X Nguyen; Barry R Thrash; Dennis J McCance
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

7.  Stimulation of lymphokines in Jurkat cells persistently infected with vaccinia virus.

Authors:  K A Stellrecht; K Sperber; B G Pogo
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

Review 8.  Cellular quiescence in mammary stem cells and breast tumor stem cells: got testable hypotheses?

Authors:  David C Harmes; James DiRenzo
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-02-25       Impact factor: 2.673

9.  Immortalized cells as experimental models to study cancer.

Authors:  Jesse S Boehm; William C Hahn
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

10.  Genetic susceptibility of cervical cancer.

Authors:  Xiaojun Chen; Jie Jiang; Hongbing Shen; Zhibin Hu
Journal:  J Biomed Res       Date:  2011-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.